Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer | |
Ling, XL; Zhang, T; Hou, XM; Zhao, D; Zhao, D (reprint author), Lanzhou Univ, Dept Oncol, Hosp 1, Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China. | |
刊名 | ONCOTARGETS AND THERAPY
![]() |
2015 | |
卷号 | 8页码:1589-1595 |
关键词 | fascin-1 NSCLC biomarker prognosis |
ISSN号 | 1178-6930 |
DOI | 10.2147/OTT.S84308 |
文献子类 | Article |
英文摘要 | Purpose: Fascin-1 promotes the formation of filopodia, lamellipodia, and microspikes of cell membrane after its cross-linking with F-actin, thereby enhancing the cell movement and metastasis and invasion of tumor cells. This study explored the fascin-1 protein's expression in non-small cell lung cancer (NSCLC) tissues and its relationship with clinical pathology and prognostic indicators. Methods: Immunohistochemical analysis was used to determine the expression of fascin-1 in NSCLC tissues. We used quantitative real-time polymerase chain reaction and western blot analysis to further verify the results. The fascin-1 expression and statistical method for clinical pathological parameters are examined by chi(2). Kaplan-Meier method is used for survival analysis. Cox's Proportional Hazard Model was used to conduct a combined-effect analysis for each covariate. Results: In 73 of the 128 cases, NSCLC cancer tissues (57.0%) were found with high expression of fascin-1, which was significantly higher than the adjacent tissues (35/128, 27.3%). The results suggested that the high expression of fascin-1 was significantly correlated with lymph node metastasis (P=0.022) and TNM stage (P=0.042). The high fascin-1 expression patients survived shorter than those NSCLC patients with low fascin-1 expression (P<0.05). Univariate analysis revealed that lymph node metastasis, TNM stage, and fascin-1 expression status were correlated with the overall survival. Similarly, lymph node metastasis, TNM stage, and fascin-1 expression status were significantly associated with the overall survival in multivariate analyses by using the Cox regression model. Conclusion: The fascin-1 protein may be a useful prognostic indicator and hopeful new target for NSCLC patients. |
学科主题 | Biotechnology & Applied Microbiology ; Oncology |
出版地 | ALBANY |
资助项目 | 甘肃省技术研究与开发专项计划 ; 甘肃省科技支撑计划 |
项目编号 | Science and Technology Project in Gansu Province of China [090NKCA126] ; Project of Special technology research and development program in Gansu Province of China [1004TCYA023] |
语种 | 英语 |
WOS记录号 | WOS:000357530400001 |
资助机构 | GSSTD |
内容类型 | 期刊论文 |
源URL | [http://ir.lzu.edu.cn/handle/262010/178525] ![]() |
专题 | 第一临床医学院_期刊论文 |
通讯作者 | Zhao, D (reprint author), Lanzhou Univ, Dept Oncol, Hosp 1, Donggang West Rd, Lanzhou 730000, Gansu, Peoples R China. |
推荐引用方式 GB/T 7714 | Ling, XL,Zhang, T,Hou, XM,et al. Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer[J]. ONCOTARGETS AND THERAPY,2015,8:1589-1595. |
APA | Ling, XL,Zhang, T,Hou, XM,Zhao, D,&Zhao, D .(2015).Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer.ONCOTARGETS AND THERAPY,8,1589-1595. |
MLA | Ling, XL,et al."Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer".ONCOTARGETS AND THERAPY 8(2015):1589-1595. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论